digest
Short Summary
Main recommendation: Dr. Jason Fung argues that LDL cholesterol is a weak risk factor for heart disease and that the 2026 American Heart Association guidelines, which push aggressive screening and drug treatment, are misguided. He says diabetes, smoking, high blood pressure, and diet-related blood sugar control deserve far more attention.
Key Points
- Fung cites the AHA's own PREVENT 10-year risk calculator (built from over 6 million patients across 45 studies) to show LDL-related non-HDL cholesterol carries a hazard ratio of about 1.0 in women and roughly 1.05 in men.
- By comparison, Fung says diabetes raises heart disease risk by about 60–65% (hazard ratio about 1.65), smoking by roughly 60%, and high blood pressure by about 36%.
- Fung cites a 1.5-million-patient study across 34 countries, published in the New England Journal of Medicine, which he says found that removing diabetes or stopping smoking substantially lowered heart disease and total mortality, while treating cholesterol had a much smaller effect and no measurable effect on overall death.
- Fung argues very low LDL is not protective: he cites a Danish study where mortality was lowest around 140 mg/dL and rose about 50% below 55 mg/dL, and he notes dialysis patients with very low LDL still have an estimated 10–20 times higher heart disease risk.
- Fung cites a 2025 NEJM analysis estimating that treating cholesterol was associated with losing 0.4–1.3 years of heart-disease-free life, while avoiding diabetes or smoking gained roughly 4–6 years.
Details Worth Noting
- Concrete instructions: The video gives no step-by-step medical protocol. Its actionable advice is to prioritize stopping smoking, managing and reducing diabetes through diet (specifically cutting carbohydrates to lower blood sugar), and monitoring and treating high blood pressure. Fung says patients should weigh the magnitude of each risk factor and the side effects and costs of statins before starting one.
- The 2026 AHA guidelines he criticizes call for cholesterol screening starting at ages 9–11, screening every 5 years from age 20, and LDL targets around 55–70 mg/dL, usually treated with drugs.
- Per a JAMA study he cites, applying these guidelines would treat about 56.5% of adults aged 30–79, rising to 85% at ages 60–69 and 93% at 70 and older, adding over 21 million people to medication.
- Fung notes triglycerides are mostly driven by dietary carbohydrates, and that statins mainly target LDL, so the non-HDL measure the AHA uses partly reflects triglycerides rather than LDL alone.
- He cites a Lancet "healthy longevity" trial of adults 75 and older finding no increase in heart disease or death when statins were stopped.
- Fung's view is contested by mainstream cardiology, which sees LDL as a causal risk factor; the video presents only his interpretation of the cited data.
Bottom Line
Fung's core message is that the evidence he presents places cholesterol far below diabetes, smoking, and blood pressure in heart disease risk, so the new guidelines' push for widespread statin use deserves skepticism; anyone considering these drugs should weigh their own risks, side effects, and costs with a clinician.
